0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-25I74
Home | Market Reports | Business & Industrial| Chemicals Industry
Global Crude Heparin Market Size Manufacturers Supply Chain Sales Channel and Clients 2021 2027
BUY CHAPTERS

Global Crude Heparin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-25I74
Report
July 2025
Pages:155
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Crude Heparin Market Size

In 2024, the global market size of Crude Heparin was estimated to be worth US$ 3640 million and is forecast to reach approximately US$ 5148 million by 2031 with a CAGR of 5.1% during the forecast period 2025-2031.

Crude Heparin Market

Crude Heparin Market

Global key players of crude heparin include Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend and Hebei Changshan Biochemical. The top five players hold a share about 46%. China is the largest market, which has a share about 56%, followed by North America and Europe, with share 19% and 18%, separately. In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%. In terms of application, LMWH holds an important share, with a share of 91%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Crude Heparin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crude Heparin.
The Crude Heparin market size, estimations, and forecasts are provided in terms of sales volume (Tons) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crude Heparin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Crude Heparin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Crude Heparin Market Report

Report Metric Details
Report Name Crude Heparin Market
CAGR 5.1%
Segment by Type
  • Pig Intestine Mucosa Heparin
  • Bovine Heparin and Others
Segment by Application
  • UFH
  • LMWH
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, Hepac (Darling Ingredients), Huaian MDC Pharmaceutical, Yantai Dongcheng Biochemicals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Crude Heparin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Crude Heparin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Crude Heparin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the market share of major companies in Crude Heparin Market?

Ans: The top five players hold a share about 46%.

What is the Crude Heparin Market share by region?

Ans: China is the largest market, which has a share about 56%, followed by North America and Europe, with share 19% and 18%, separately.

What is the Crude Heparin Market share by type?

Ans: In terms of product type, Pig Intestine Mucosa Heparin plays an important role with a share over 99%.

What is the Crude Heparin Market share by application?

Ans: In terms of application, LMWH holds an important share, with a share of 91%.

Who are the main players in the Crude Heparin Market report?

Ans: The main players in the Crude Heparin Market are Bioiberica, Shenzhen Hepalink, Sanofi, Nanjing King-friend, Fengrun Biological Technology, Aspen Oss, Hebei Changshan Biochemical, Changzhou Qianhong, Hepac (Darling Ingredients), Huaian MDC Pharmaceutical, Yantai Dongcheng Biochemicals

What are the Application segmentation covered in the Crude Heparin Market report?

Ans: The Applications covered in the Crude Heparin Market report are UFH, LMWH

What are the Type segmentation covered in the Crude Heparin Market report?

Ans: The Types covered in the Crude Heparin Market report are Pig Intestine Mucosa Heparin, Bovine Heparin and Others

1 Study Coverage
1.1 Crude Heparin Product Introduction
1.2 Market by Type
1.2.1 Global Crude Heparin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 Pig Intestine Mucosa Heparin
1.2.3 Bovine Heparin and Others
1.3 Market by Application
1.3.1 Global Crude Heparin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 UFH
1.3.3 LMWH
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Crude Heparin Market Size Estimates and Forecasts
2.1.1 Global Crude Heparin Revenue 2020-2031
2.1.2 Global Crude Heparin Sales 2020-2031
2.2 Crude Heparin Market Size by Region: 2024 Versus 2031
2.3 Crude Heparin Sales by Region (2020-2031)
2.3.1 Global Crude Heparin Sales by Region: 2020-2025
2.3.2 Global Crude Heparin Sales Forecast by Region (2026-2031)
2.3.3 Global Crude Heparin Sales Market Share by Region (2020-2031)
2.4 Crude Heparin Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Crude Heparin Revenue by Region: 2020-2025
2.4.2 Global Crude Heparin Revenue Forecast by Region (2026-2031)
2.4.3 Global Crude Heparin Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Crude Heparin Sales by Type (2020-2031)
3.1.1.1 Global Crude Heparin Sales Volume by Type (2020-2031)
3.1.1.2 Global Crude Heparin Sales Market Share by Type (2020-2031)
3.1.2 Global Crude Heparin Revenue by Type (2020-2031)
3.1.2.1 Global Crude Heparin Revenue by Type (2020-2031)
3.1.2.2 Global Crude Heparin Revenue Market Share by Type (2020-2031)
3.1.3 Crude Heparin Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Crude Heparin Sales by Application (2020-2031)
3.2.1.1 Global Crude Heparin Sales Volume by Application (2020-2031)
3.2.1.2 Global Crude Heparin Sales Market Share by Application (2020-2031)
3.2.2 Global Crude Heparin Revenue by Application (2020-2031)
3.2.2.1 Global Crude Heparin Revenue by Application (2020-2031)
3.2.2.2 Global Crude Heparin Revenue Market Share by Application (2020-2031)
3.2.3 Crude Heparin Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 Pig Intestine Mucosa Heparin of Crude Heparin Revenue Market Share by Application
3.3.2 Bovine Heparin and Others of Crude Heparin Revenue Market Share by Application
4 Global Crude Heparin by Manufacturers
4.1 Global Top Crude Heparin Manufacturers by Sales (2020-2025)
4.1.1 Global Crude Heparin Sales by Manufacturer (2020-2025)
4.1.2 Global Crude Heparin Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Crude Heparin Manufacturers by Revenue (2020-2025)
4.2.1 Global Crude Heparin Revenue by Manufacturer (2020-2025)
4.2.2 Global Crude Heparin Revenue Share by Manufacturer (2020-2025)
4.3 Global Crude Heparin Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Crude Heparin Manufacturers Covered: Ranking by Revenue
4.4.2 Global Crude Heparin Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Crude Heparin Manufacturing Base Distribution, Product Type
4.5.1 Crude Heparin Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Crude Heparin Market
4.5.3 Manufacturers Crude Heparin Product Type and Application
4.5.4 Pig Intestine Mucosa Heparin Market Sales of Crude Heparin by Manufacturer
4.5.5 Bovine Heparin and Others Market Sales of Crude Heparin by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Bioiberica
5.1.1 Bioiberica Company Information
5.1.2 Bioiberica Description, Business Overview
5.1.3 Bioiberica Crude Heparin Products Offered
5.1.4 Bioiberica Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Bioiberica Crude Heparin Sales by Product in 2024
5.1.6 Bioiberica Crude Heparin Sales by Application in 2024
5.1.7 Bioiberica Crude Heparin Sales by Geographic Area in 2024
5.1.8 Bioiberica Recent Developments
5.2 Shenzhen Hepalink
5.2.1 Shenzhen Hepalink Company Information
5.2.2 Shenzhen Hepalink Description, Business Overview
5.2.3 Shenzhen Hepalink Crude Heparin Products Offered
5.2.4 Shenzhen Hepalink Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Shenzhen Hepalink Crude Heparin Sales by Product in 2024
5.2.6 Shenzhen Hepalink Crude Heparin Sales by Application in 2024
5.2.7 Shenzhen Hepalink Crude Heparin Sales by Geographic Area in 2024
5.2.8 Shenzhen Hepalink Recent Developments
5.3 Sanofi
5.3.1 Sanofi Company Information
5.3.2 Sanofi Description, Business Overview
5.3.3 Sanofi Crude Heparin Products Offered
5.3.4 Sanofi Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Sanofi Crude Heparin Sales by Product in 2024
5.3.6 Sanofi Crude Heparin Sales by Application in 2024
5.3.7 Sanofi Crude Heparin Sales by Geographic Area in 2024
5.3.8 Sanofi Recent Developments
5.4 Nanjing King-friend
5.4.1 Nanjing King-friend Company Information
5.4.2 Nanjing King-friend Description, Business Overview
5.4.3 Nanjing King-friend Crude Heparin Products Offered
5.4.4 Nanjing King-friend Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.4.5 Nanjing King-friend Crude Heparin Sales by Product in 2024
5.4.6 Nanjing King-friend Crude Heparin Sales by Application in 2024
5.4.7 Nanjing King-friend Crude Heparin Sales by Geographic Area in 2024
5.4.8 Nanjing King-friend Recent Developments
5.5 Fengrun Biological Technology
5.5.1 Fengrun Biological Technology Company Information
5.5.2 Fengrun Biological Technology Description, Business Overview
5.5.3 Fengrun Biological Technology Crude Heparin Products Offered
5.5.4 Fengrun Biological Technology Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Fengrun Biological Technology Crude Heparin Sales by Product in 2024
5.5.6 Fengrun Biological Technology Crude Heparin Sales by Application in 2024
5.5.7 Fengrun Biological Technology Crude Heparin Sales by Geographic Area in 2024
5.5.8 Fengrun Biological Technology Recent Developments
5.6 Aspen Oss
5.6.1 Aspen Oss Company Information
5.6.2 Aspen Oss Description, Business Overview
5.6.3 Aspen Oss Crude Heparin Products Offered
5.6.4 Aspen Oss Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.6.5 Aspen Oss Crude Heparin Sales by Product in 2024
5.6.6 Aspen Oss Crude Heparin Sales by Application in 2024
5.6.7 Aspen Oss Crude Heparin Sales by Geographic Area in 2024
5.6.8 Aspen Oss Recent Developments
5.7 Hebei Changshan Biochemical
5.7.1 Hebei Changshan Biochemical Company Information
5.7.2 Hebei Changshan Biochemical Description, Business Overview
5.7.3 Hebei Changshan Biochemical Crude Heparin Products Offered
5.7.4 Hebei Changshan Biochemical Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.7.5 Hebei Changshan Biochemical Crude Heparin Sales by Product in 2024
5.7.6 Hebei Changshan Biochemical Crude Heparin Sales by Application in 2024
5.7.7 Hebei Changshan Biochemical Crude Heparin Sales by Geographic Area in 2024
5.7.8 Hebei Changshan Biochemical Recent Developments
5.8 Changzhou Qianhong
5.8.1 Changzhou Qianhong Company Information
5.8.2 Changzhou Qianhong Description, Business Overview
5.8.3 Changzhou Qianhong Crude Heparin Products Offered
5.8.4 Changzhou Qianhong Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.8.5 Changzhou Qianhong Crude Heparin Sales by Product in 2024
5.8.6 Changzhou Qianhong Crude Heparin Sales by Application in 2024
5.8.7 Changzhou Qianhong Crude Heparin Sales by Geographic Area in 2024
5.8.8 Changzhou Qianhong Recent Developments
5.9 Hepac (Darling Ingredients)
5.9.1 Hepac (Darling Ingredients) Company Information
5.9.2 Hepac (Darling Ingredients) Description, Business Overview
5.9.3 Hepac (Darling Ingredients) Crude Heparin Products Offered
5.9.4 Hepac (Darling Ingredients) Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.9.5 Hepac (Darling Ingredients) Crude Heparin Sales by Product in 2024
5.9.6 Hepac (Darling Ingredients) Crude Heparin Sales by Application in 2024
5.9.7 Hepac (Darling Ingredients) Crude Heparin Sales by Geographic Area in 2024
5.9.8 Hepac (Darling Ingredients) Recent Developments
5.10 Huaian MDC Pharmaceutical
5.10.1 Huaian MDC Pharmaceutical Company Information
5.10.2 Huaian MDC Pharmaceutical Description, Business Overview
5.10.3 Huaian MDC Pharmaceutical Crude Heparin Products Offered
5.10.4 Huaian MDC Pharmaceutical Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.10.5 Huaian MDC Pharmaceutical Crude Heparin Sales by Product in 2024
5.10.6 Huaian MDC Pharmaceutical Crude Heparin Sales by Application in 2024
5.10.7 Huaian MDC Pharmaceutical Crude Heparin Sales by Geographic Area in 2024
5.10.8 Huaian MDC Pharmaceutical Recent Developments
5.11 Yantai Dongcheng Biochemicals
5.11.1 Yantai Dongcheng Biochemicals Company Information
5.11.2 Yantai Dongcheng Biochemicals Description, Business Overview
5.11.3 Yantai Dongcheng Biochemicals Crude Heparin Products Offered
5.11.4 Yantai Dongcheng Biochemicals Crude Heparin Sales, Revenue and Gross Margin (2020-2025)
5.11.5 Yantai Dongcheng Biochemicals Crude Heparin Sales by Product in 2024
5.11.6 Yantai Dongcheng Biochemicals Crude Heparin Sales by Application in 2024
5.11.7 Yantai Dongcheng Biochemicals Crude Heparin Sales by Geographic Area in 2024
5.11.8 Yantai Dongcheng Biochemicals Recent Developments
6 North America
6.1 North America Crude Heparin Market Size YoY Growth 2020-2031
6.2 North America Crude Heparin Market Facts & Figures by Country
6.2.1 North America Crude Heparin Sales by Country (2020-2031)
6.2.2 North America Crude Heparin Revenue by Country (2020-2031)
6.3 North America Crude Heparin Sales by Type (2020-2025)
6.4 North America Crude Heparin Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Crude Heparin Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Crude Heparin Market Facts & Figures by Region
7.2.1 Asia-Pacific Crude Heparin Sales by Region (2020-2031)
7.2.2 Asia-Pacific Crude Heparin Revenue by Region (2020-2031)
7.3 Asia-Pacific Crude Heparin Sales by Type (2020-2025)
7.4 Asia-Pacific Crude Heparin Sales by Application (2020-2025)
8 Europe
8.1 Europe Crude Heparin Market Size YoY Growth 2020-2031
8.2 Europe Crude Heparin Market Facts & Figures by Country
8.2.1 Europe Crude Heparin Sales by Country (2020-2031)
8.2.2 Europe Crude Heparin Revenue by Country (2020-2031)
8.3 Europe Crude Heparin Sales by Type (2020-2025)
8.4 Europe Crude Heparin Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Crude Heparin Market Size YoY Growth 2020-2031
9.2 Latin America Crude Heparin Market Facts & Figures by Country
9.2.1 Latin America Crude Heparin Sales by Country (2020-2031)
9.2.2 Latin America Crude Heparin Revenue by Country (2020-2031)
9.3 Latin America Crude Heparin Sales by Type (2020-2025)
9.4 Latin America Crude Heparin Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Crude Heparin Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Crude Heparin Market Facts & Figures by Country
10.2.1 Middle East and Africa Crude Heparin Sales by Country (2020-2031)
10.2.2 Middle East and Africa Crude Heparin Revenue by Country (2020-2031)
10.3 Middle East and Africa Crude Heparin Sales by Type (2020-2025)
10.4 Middle East and Africa Crude Heparin Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Crude Heparin Supply Chain Analysis
11.2 Crude Heparin Key Raw Materials and Upstream Suppliers
11.3 Crude Heparin Clients Analysis
11.4 Crude Heparin Sales Channel and Sales Model Analysis
11.4.1 Crude Heparin Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Crude Heparin Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Crude Heparin Distributors
12 Crude Heparin Market Dynamics
12.1 Crude Heparin Industry Trends
12.2 Crude Heparin Market Drivers
12.3 Crude Heparin Market Challenges
12.4 Crude Heparin Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Crude Heparin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Crude Heparin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Crude Heparin Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Crude Heparin Sales by Region (2020-2025) & (Tons)
 Table 5. Global Crude Heparin Sales Forecast by Region (2026-2031) & (Tons)
 Table 6. Global Crude Heparin Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Crude Heparin Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Crude Heparin Sales Volume by Type (2020-2025) & (Tons)
 Table 9. Global Crude Heparin Sales Volume by Type (2026-2031) & (Tons)
 Table 10. Global Crude Heparin Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Crude Heparin Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Crude Heparin Sales Volume by Application (2020-2025) & (Tons)
 Table 13. Global Crude Heparin Sales Volume by Application (2026-2031) & (Tons)
 Table 14. Global Crude Heparin Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Crude Heparin Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Crude Heparin Sales by Manufacturer (2020-2025) & (Tons)
 Table 17. Global Crude Heparin Sales Share by Manufacturer (2020-2025)
 Table 18. Crude Heparin Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Crude Heparin Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Crude Heparin Price (2020-2025) & (US$/Kg)
 Table 21. Ranking of Global Top Crude Heparin Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Crude Heparin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Crude Heparin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crude Heparin as of 2024)
 Table 24. Crude Heparin Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Crude Heparin Market
 Table 26. Manufacturers Crude Heparin Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Bioiberica Company Information
 Table 29. Bioiberica Description and Business Overview
 Table 30. Bioiberica Crude Heparin Product
 Table 31. Bioiberica Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 32. Bioiberica Sales Proportion of Crude Heparin by Product in 2024
 Table 33. Bioiberica Sales Proportion of Crude Heparin by Application in 2024
 Table 34. Bioiberica Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 35. Bioiberica Recent Developments
 Table 36. Shenzhen Hepalink Company Information
 Table 37. Shenzhen Hepalink Description and Business Overview
 Table 38. Shenzhen Hepalink Crude Heparin Product
 Table 39. Shenzhen Hepalink Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 40. Shenzhen Hepalink Sales Proportion of Crude Heparin by Product in 2024
 Table 41. Shenzhen Hepalink Sales Proportion of Crude Heparin by Application in 2024
 Table 42. Shenzhen Hepalink Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 43. Shenzhen Hepalink Recent Developments
 Table 44. Sanofi Company Information
 Table 45. Sanofi Description and Business Overview
 Table 46. Sanofi Crude Heparin Product
 Table 47. Sanofi Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 48. Sanofi Sales Proportion of Crude Heparin by Product in 2024
 Table 49. Sanofi Sales Proportion of Crude Heparin by Application in 2024
 Table 50. Sanofi Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 51. Sanofi Recent Developments
 Table 52. Nanjing King-friend Company Information
 Table 53. Nanjing King-friend Description and Business Overview
 Table 54. Nanjing King-friend Crude Heparin Product
 Table 55. Nanjing King-friend Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 56. Nanjing King-friend Sales Proportion of Crude Heparin by Product in 2024
 Table 57. Nanjing King-friend Sales Proportion of Crude Heparin by Application in 2024
 Table 58. Nanjing King-friend Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 59. Nanjing King-friend Recent Developments
 Table 60. Fengrun Biological Technology Company Information
 Table 61. Fengrun Biological Technology Description and Business Overview
 Table 62. Fengrun Biological Technology Crude Heparin Product
 Table 63. Fengrun Biological Technology Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 64. Fengrun Biological Technology Sales Proportion of Crude Heparin by Product in 2024
 Table 65. Fengrun Biological Technology Sales Proportion of Crude Heparin by Application in 2024
 Table 66. Fengrun Biological Technology Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 67. Fengrun Biological Technology Recent Developments
 Table 68. Aspen Oss Company Information
 Table 69. Aspen Oss Description and Business Overview
 Table 70. Aspen Oss Crude Heparin Product
 Table 71. Aspen Oss Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 72. Aspen Oss Sales Proportion of Crude Heparin by Product in 2024
 Table 73. Aspen Oss Sales Proportion of Crude Heparin by Application in 2024
 Table 74. Aspen Oss Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 75. Aspen Oss Recent Developments
 Table 76. Hebei Changshan Biochemical Company Information
 Table 77. Hebei Changshan Biochemical Description and Business Overview
 Table 78. Hebei Changshan Biochemical Crude Heparin Product
 Table 79. Hebei Changshan Biochemical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 80. Hebei Changshan Biochemical Sales Proportion of Crude Heparin by Product in 2024
 Table 81. Hebei Changshan Biochemical Sales Proportion of Crude Heparin by Application in 2024
 Table 82. Hebei Changshan Biochemical Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 83. Hebei Changshan Biochemical Recent Developments
 Table 84. Changzhou Qianhong Company Information
 Table 85. Changzhou Qianhong Description and Business Overview
 Table 86. Changzhou Qianhong Crude Heparin Product
 Table 87. Changzhou Qianhong Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 88. Changzhou Qianhong Sales Proportion of Crude Heparin by Product in 2024
 Table 89. Changzhou Qianhong Sales Proportion of Crude Heparin by Application in 2024
 Table 90. Changzhou Qianhong Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 91. Changzhou Qianhong Recent Developments
 Table 92. Hepac (Darling Ingredients) Company Information
 Table 93. Hepac (Darling Ingredients) Description and Business Overview
 Table 94. Hepac (Darling Ingredients) Crude Heparin Product
 Table 95. Hepac (Darling Ingredients) Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 96. Hepac (Darling Ingredients) Sales Proportion of Crude Heparin by Product in 2024
 Table 97. Hepac (Darling Ingredients) Sales Proportion of Crude Heparin by Application in 2024
 Table 98. Hepac (Darling Ingredients) Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 99. Hepac (Darling Ingredients) Recent Developments
 Table 100. Huaian MDC Pharmaceutical Company Information
 Table 101. Huaian MDC Pharmaceutical Description and Business Overview
 Table 102. Huaian MDC Pharmaceutical Crude Heparin Product
 Table 103. Huaian MDC Pharmaceutical Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 104. Huaian MDC Pharmaceutical Sales Proportion of Crude Heparin by Product in 2024
 Table 105. Huaian MDC Pharmaceutical Sales Proportion of Crude Heparin by Application in 2024
 Table 106. Huaian MDC Pharmaceutical Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 107. Huaian MDC Pharmaceutical Recent Developments
 Table 108. Yantai Dongcheng Biochemicals Company Information
 Table 109. Yantai Dongcheng Biochemicals Description and Business Overview
 Table 110. Yantai Dongcheng Biochemicals Crude Heparin Product
 Table 111. Yantai Dongcheng Biochemicals Crude Heparin Sales (Tons), Revenue (US$ Million), Price (US$/Kg) and Gross Margin (2020-2025)
 Table 112. Yantai Dongcheng Biochemicals Sales Proportion of Crude Heparin by Product in 2024
 Table 113. Yantai Dongcheng Biochemicals Sales Proportion of Crude Heparin by Application in 2024
 Table 114. Yantai Dongcheng Biochemicals Sales Proportion of Crude Heparin by Geographic Area in 2024
 Table 115. Yantai Dongcheng Biochemicals Recent Developments
 Table 116. North America Crude Heparin Sales by Country (2020-2025) & (Tons)
 Table 117. North America Crude Heparin Sales by Country (2026-2031) & (Tons)
 Table 118. North America Crude Heparin Revenue by Country (2020-2025) & (US$ Million)
 Table 119. North America Crude Heparin Revenue by Country (2026-2031) & (US$ Million)
 Table 120. North America Crude Heparin Sales by Type (2020-2025) & (Tons)
 Table 121. North America Crude Heparin Sales by Application (2020-2025) & (Tons)
 Table 122. Asia-Pacific Crude Heparin Sales by Region (2020-2025) & (Tons)
 Table 123. Asia-Pacific Crude Heparin Sales by Region (2026-2031) & (Tons)
 Table 124. Asia-Pacific Crude Heparin Revenue by Region (2020-2025) & (US$ Million)
 Table 125. Asia-Pacific Crude Heparin Revenue by Region (2026-2031) & (US$ Million)
 Table 126. Asia-Pacific Crude Heparin Sales by Type (2020-2025) & (Tons)
 Table 127. Asia-Pacific Crude Heparin Sales by Application (2020-2025) & (Tons)
 Table 128. Europe Crude Heparin Sales by Country (2020-2025) & (Tons)
 Table 129. Europe Crude Heparin Sales by Country (2026-2031) & (Tons)
 Table 130. Europe Crude Heparin Revenue by Country (2020-2025) & (US$ Million)
 Table 131. Europe Crude Heparin Revenue by Country (2026-2031) & (US$ Million)
 Table 132. Europe Crude Heparin Sales by Type (2020-2025) & (Tons)
 Table 133. Europe Crude Heparin Sales by Application (2020-2025) & (Tons)
 Table 134. Latin America Crude Heparin Sales by Country (2020-2025) & (Tons)
 Table 135. Latin America Crude Heparin Sales by Country (2026-2031) & (Tons)
 Table 136. Latin America Crude Heparin Revenue by Country (2020-2025) & (US$ Million)
 Table 137. Latin America Crude Heparin Revenue by Country (2026-2031) & (US$ Million)
 Table 138. Latin America Crude Heparin Sales by Type (2020-2025) & (Tons)
 Table 139. Latin America Crude Heparin Sales by Application (2020-2025) & (Tons)
 Table 140. Middle East and Africa Crude Heparin Sales by Country (2020-2025) & (Tons)
 Table 141. Middle East and Africa Crude Heparin Sales by Country (2026-2031) & (Tons)
 Table 142. Middle East and Africa Crude Heparin Revenue by Country (2020-2025) & (US$ Million)
 Table 143. Middle East and Africa Crude Heparin Revenue by Country (2026-2031) & (US$ Million)
 Table 144. Middle East and Africa Crude Heparin Sales by Type (2020-2025) & (Tons)
 Table 145. Middle East and Africa Crude Heparin Sales by Application (2020-2025) & (Tons)
 Table 146. Crude Heparin Key Raw Materials, Industry Status and Trend
 Table 147. Crude Heparin Key Raw Materials and Upstream Suppliers
 Table 148. Crude Heparin Clients Status and Trend
 Table 149. Crude Heparin Typical Clients
 Table 150. Crude Heparin Distributors
 Table 151. Crude Heparin Market Trends
 Table 152. Crude Heparin Market Drivers
 Table 153. Crude Heparin Market Challenges
 Table 154. Crude Heparin Market Restraints
 Table 155. Research Programs/Design for This Report
 Table 156. Key Data Information from Secondary Sources
 Table 157. Key Data Information from Primary Sources
 Table 158. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Crude Heparin Product Picture
 Figure 2. Global Crude Heparin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Crude Heparin Sales Market Share by Type in 2024 & 2031
 Figure 4. Pig Intestine Mucosa Heparin Product Picture
 Figure 5. Bovine Heparin and Others Product Picture
 Figure 6. Global Crude Heparin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Crude Heparin Sales Market Share by Application in 2024 & 2031
 Figure 8. UFH
 Figure 9. LMWH
 Figure 10. Crude Heparin Report Years Considered
 Figure 11. Global Crude Heparin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Crude Heparin Market Size 2020-2031 (US$ Million)
 Figure 13. Global Crude Heparin Sales 2020-2031 (Tons)
 Figure 14. Global Crude Heparin Sales Market Share Forecast by Region (2020-2031)
 Figure 15. Global Crude Heparin Revenue Market Share by Region (2020-2031)
 Figure 16. Global Crude Heparin Sales Market Share Forecast by Type (2020-2031)
 Figure 17. Global Crude Heparin Revenue Market Share Forecast by Type (2020-2031)
 Figure 18. Crude Heparin Average Selling Price (ASP) by Type (2020-2025) & (US$/Kg)
 Figure 19. Global Crude Heparin Sales Market Share Forecast by Application (2020-2031)
 Figure 20. Global Crude Heparin Revenue Market Share Forecast by Application (2020-2031)
 Figure 21. Crude Heparin Average Selling Price (ASP) by Application (2020-2025) & (US$/Kg)
 Figure 22. Pig Intestine Mucosa Heparin of Crude Heparin Revenue Market Share by Application, 2024 VS 2031
 Figure 23. Bovine Heparin and Others of Crude Heparin Revenue Market Share by Application, 2024 VS 2031
 Figure 24. Global Crude Heparin Sales Share by Manufacturer in 2024
 Figure 25. Crude Heparin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 26. Pig Intestine Mucosa Heparin Market Sales Proportion by Manufacturer in 2024
 Figure 27. Bovine Heparin and Others Market Sales Proportion by Manufacturer in 2024
 Figure 28. North America Crude Heparin Revenue 2020-2031 (US$ Million)
 Figure 29. North America Crude Heparin Sales Market Share by Type (2020-2025)
 Figure 30. North America Crude Heparin Sales Market Share by Application (2020-2025)
 Figure 31. Asia-Pacific Crude Heparin Revenue 2020-2031 (US$ Million)
 Figure 32. Asia-Pacific Crude Heparin Sales Market Share by Region (2020-2031)
 Figure 33. Asia-Pacific Crude Heparin Revenue Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Crude Heparin Sales Market Share by Type (2020-2025)
 Figure 35. Asia-Pacific Crude Heparin Sales Market Share by Application (2020-2025)
 Figure 36. Europe Crude Heparin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 37. Europe Crude Heparin Sales Market Share by Country (2020-2031)
 Figure 38. Europe Crude Heparin Revenue Market Share by Country (2020-2031)
 Figure 39. Europe Crude Heparin Sales Market Share by Type (2020-2025)
 Figure 40. Europe Crude Heparin Sales Market Share by Application (2020-2025)
 Figure 41. Latin America Crude Heparin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 42. Latin America Crude Heparin Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Crude Heparin Revenue Market Share by Country (2020-2025)
 Figure 44. Latin America Crude Heparin Sales Market Share by Type (2020-2025)
 Figure 45. Latin America Crude Heparin Sales Market Share by Application (2020-2025)
 Figure 46. Middle East and Africa Crude Heparin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 47. Middle East and Africa Crude Heparin Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Crude Heparin Revenue Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Crude Heparin Sales Market Share by Type (2020-2025)
 Figure 50. Middle East and Africa Crude Heparin Sales Market Share by Application (2020-2025)
 Figure 51. Crude Heparin Supply Chain (Upstream and Downstream Market)
 Figure 52. Global Production Market Share of Crude Heparin Raw Materials by Region in 2024
 Figure 53. Crude Heparin Distribution Channels
 Figure 54. Global Crude Heparin Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 55. Global Crude Heparin Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 56. Bottom-up and Top-down Approaches for This Report
 Figure 57. Data Triangulation
 Figure 58. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture

SIMILAR REPORTS